A detailed history of Xponance, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Xponance, Inc. holds 12,005 shares of OGN stock, worth $181,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,005
Holding current value
$181,035
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$14.44 - $18.83 $173,352 - $226,054
12,005 New
12,005 $179,000
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $39,231 - $53,523
2,847 Added 26.27%
13,683 $257,000
Q4 2023

Jan 31, 2024

SELL
$10.95 - $17.32 $347,104 - $549,026
-31,699 Reduced 74.52%
10,836 $156,000
Q3 2023

Oct 23, 2023

BUY
$16.59 - $23.77 $29,828 - $42,738
1,798 Added 4.41%
42,535 $738,000
Q2 2023

Jul 13, 2023

BUY
$19.27 - $24.63 $32,161 - $41,107
1,669 Added 4.27%
40,737 $847,000
Q1 2023

Apr 17, 2023

BUY
$21.42 - $32.08 $51,043 - $76,446
2,383 Added 6.5%
39,068 $918,000
Q4 2022

Jan 23, 2023

BUY
$23.31 - $28.61 $147,832 - $181,444
6,342 Added 20.9%
36,685 $0
Q3 2022

Oct 24, 2022

BUY
$23.4 - $34.25 $127,249 - $186,251
5,438 Added 21.83%
30,343 $710,000
Q2 2022

Aug 02, 2022

BUY
$31.66 - $38.9 $284,623 - $349,711
8,990 Added 56.49%
24,905 $841,000
Q1 2022

Apr 20, 2022

BUY
$30.45 - $39.36 $15,194 - $19,640
499 Added 3.24%
15,915 $556,000
Q4 2021

Jan 31, 2022

BUY
$28.67 - $37.13 $78,240 - $101,327
2,729 Added 21.51%
15,416 $469,000
Q3 2021

Nov 05, 2021

SELL
$28.63 - $35.64 $46,180 - $57,487
-1,613 Reduced 11.28%
12,687 $416,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $406,835 - $543,400
14,300 New
14,300 $433,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.84B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.